Educational Webinars
Qiagen sponsors continuing medical educational events for healthcare professionals across the country. You can register for upcoming sessions here, or watch archived webinar recordings at any time, from anywhere. These events are presented by respected professionals in the world of healthcare and research, and managed by Whitehat Communications to ensure a professional environment. All programs are free, and offer one P.A.C.E.® Continuing Education contact hour for up to six months after the live event. Be sure to check back often for new event postings.  Clinical Laboratory Tests to Assess Fetal and Neonatal Status Live Event: Wednesday, April 15, 2020 PACE® Credit available until October 15, 2020  |  Florida Lab Credit available The neonatal period is the most vulnerable time for a child. If the child is born prematurely, there are additional risks during the neonatal period. In the United States, about 380,000 babies are born prematurely (before 37 weeks) each year. The preterm birth rate is 9.8%, meaning 1 in 10 babies is born too soon1. The accurate and timely identification of clinical parameters related to rupture of membranes (ROM), intrapartum fetal health as well as neonatal health is paramount to reduce neonatal morbidity and mortality. •  Rupture of membranes and its associated complications are leading causes of neonatal morbidity and mortality. •  Fetal scalp lactate measurement has been used as an adjunct to electronic fetal monitoring to assess fetal well-being intrapartum. •  Although there is ongoing debate regarding the relationship between neonatal hypoglycemia and negative neurodevelopmental outcomes, the measurement and interpretation of time-dependent blood glucose levels are embedded into standard clinical practice to assess neonatal health. The overall goal of this webinar is to review the performance of selective clinical laboratory tests to assess the risk of preterm delivery, intrapartum fetal as well as neonatal health. References: 1 “Fighting premature birth: the prematurity campaign.” March of Dimes. Accessed March 10, 2020. https://www.marchofdimes.org/mission/prematurity-campaign.aspx This session will: Discuss the clinical utility of, placental alpha microglobulin-1 and insulin like growth factor binding protein-1 to detect premature rupture of membranes Describe the clinical utility of measuring fetal scalp lactate to detect intrapartum hypoxia and describe the impact of analytical error in lactate measurement on the misclassification of patients Examine the clinical utility of measuring glucose to detect neonatal hypoglycemia and to describe the impact of analytical error on the misclassification of patients. Presenter: Martha Lyon, PhD Clinical Biochemist, Royal University Hospital Saskatoon, Saskatchewan, Canada Dr. Martha Lyon is a clinical biochemist at Royal University Hospital in Saskatoon, Saskatchewan, Canada. Her primary clinical duties encompass Pediatric and Neonatal Clinical Biochemistry and Point of Care Testing. She has also served on provincial and international committees related to Pediatrics and Point of Care Testing.   Whitehat Communications is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.   Additional Educational Resources Sponsored by Qiagen Qiagen's commitment to education extends to our sponsorship of the long-running point of care group webinars, which are produced by Whitehat Communications and free to the point of care and laboratory community. You can register for the 2020 sessions a by visiting: 2020 Point of Care Group Webinars   © 2020 | Whitehat Communications, a division of Martek Inc.